Pulmicort and Clostridium difficile colitis - a phase IV clinical study of FDA data

Summary:

Clostridium difficile colitis is reported as a side effect among people who take Pulmicort (budesonide), especially for people who are male, 60+ old, also take Xopenex, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Clostridium difficile colitis when taking Pulmicort. It is created by eHealthMe based on reports of 34,552 people who have side effects when taking Pulmicort from the FDA, and is updated regularly.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

What is Clostridium difficile colitis?

Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection) is found to be associated with 1,042 drugs and 1,782 conditions by eHealthMe. Check the latest studies of Clostridium difficile colitis.

On Jul, 10, 2026

34,552 people reported to have side effects when taking Pulmicort.
Among them, 41 people (0.12%) have Clostridium difficile colitis.

Could Pulmicort cause Clostridium difficile colitis?

Among these 41 people:

What is the gender of people who have Clostridium difficile colitis when taking Pulmicort? *

female: 42.5 %
male: 57.5 %

What is the age of people who have Clostridium difficile colitis when taking Pulmicort? *

What are other drugs people take besides Pulmicort? *

What are other side effects people have besides Clostridium difficile colitis? *

Pneumonia: 18 people, 43.90%
Abdominal Pain: 12 people, 29.27%
Sinusitis (inflammation of sinus): 12 people, 29.27%
Diarrhea: 10 people, 24.39%
Fever: 9 people, 21.95%
Infusion Site Bruising: 8 people, 19.51%
Nausea And Vomiting: 8 people, 19.51%
Fatigue (feeling of tiredness): 8 people, 19.51%
Lower Limb Fracture: 7 people, 17.07%
Dyspnea (difficult or laboured breathing): 7 people, 17.07%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 11 people, 26.83%
Urination - Excessive Volume: 8 people, 19.51%
Superinfection Bacterial: 8 people, 19.51%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 12.20%
High Blood Pressure: 5 people, 12.20%
Anaemia (lack of blood): 4 people, 9.76%
Gastritis - Chronic (long lasting inflammation of stomach): 4 people, 9.76%
Colitis (inflammation of colon): 3 people, 7.32%
Eosinophilic Pneumonia Chronic (eosinophil accumulates in the lung-chronic): 3 people, 7.32%
Nausea (feeling of having an urge to vomit): 2 people, 4.88%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmicort and have Clostridium difficile colitis?

- Check whether Clostridium difficile colitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pulmicort:

Pulmicort (34,980 reports)

Browse all side effects of Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Clostridium difficile colitis:

Clostridium difficile colitis (1,042 drugs)

Browse all the conditions that are associated with Clostridium difficile colitis:

Clostridium difficile colitis (1,782 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on budesonide (the active ingredients of Pulmicort) and Pulmicort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.